S. Sitkin, E. Avalueva, I. Bakulin, M. I. Skalinskaya, S. Vorobyev, E. Pavlova, A. Khavkin
{"title":"The role of bacterial, fungal, and viral infections in the pathogenesis of inflammatory bowel disease","authors":"S. Sitkin, E. Avalueva, I. Bakulin, M. I. Skalinskaya, S. Vorobyev, E. Pavlova, A. Khavkin","doi":"10.20953/1729-9225-2023-2-64-81","DOIUrl":null,"url":null,"abstract":"Inflammatory bowel disease (IBD) is a group of phenotypically similar diseases characterized by multiple organ damage with predominant localization in the gastrointestinal tract and conditionally divided into two nosologies, ulcerative colitis (UC) and Crohn's disease (CD). IBD is closely associated with taxonomic and functional dysbiosis, however, to date, no study has confirmed that a single specific microorganism is the direct cause of IBD according to Koch’s postulates. The complexity of the etiology and pathogenesis of IBD determines the high interest in studying the infectious factor, not as the only causally significant factor, but as a trigger and/or comorbid one. The review summarizes current data on the involvement of the most important microorganisms (pathogens, opportunistic microorganisms, and pathobionts) in the pathogenesis of UC and CD and considers their possible role in the induction, progression, and course of IBD. A possible relationship between IBD and bacteria belonging to the phyla Pseudomonadota ( Proteobacteria), Bacillota ( Firmicutes), Actinomycetota ( Actinobacteria), and Spirochaetota, archaea, fungi, and eukaryotic viruses is discussed. Bacteria such as adhesive-invasive strains of Escherichia coli (AIEC), Salmonella enterica Typhimurium, Campylobacter jejuni, Campylobacter concisus, enterohepatic species of Helicobacter (including Helicobacter bilis), Proteus spp., Aeromonas spp., Klebsiella pneumoniae, Yersinia enterocolitica, Clostridioides difficile, Enterococcus spp., Staphylococcus aureus, Mycobacterium avium subsp. paratuberculosis and Brachyspira spp. The involvement of methanogenic archaea, such as Methanobrevibacter smithii and Methanosphaera stadtmanae, in immunoinflammatory processes in IBD has been shown. The pro-inflammatory role of intestinal fungi Candida albicans, which produces the cytolytic toxin candidalysin, Candida tropicalis, which forms polymicrobial biofilms, and Debaryomyces hansenii, has been revealed. The role of eukaryotic viruses such as herpesviruses (cytomegalovirus, Epstein–Barr virus, human herpesvirus 6), enteropathogenic viruses (norovirus), enterovirus B, hepatitis B virus (Orthohepadnavirus) in the development of IBD is discussed. Particular attention is paid to the possible role of the SARS-CoV-2 (COVID-19) virus as a trigger of IBD. Key words: inflammatory bowel disease, infections, archaea, bacteria, viruses, fungi, dysbiosis, gut microbiota","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infektsionnye Bolezni","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20953/1729-9225-2023-2-64-81","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Inflammatory bowel disease (IBD) is a group of phenotypically similar diseases characterized by multiple organ damage with predominant localization in the gastrointestinal tract and conditionally divided into two nosologies, ulcerative colitis (UC) and Crohn's disease (CD). IBD is closely associated with taxonomic and functional dysbiosis, however, to date, no study has confirmed that a single specific microorganism is the direct cause of IBD according to Koch’s postulates. The complexity of the etiology and pathogenesis of IBD determines the high interest in studying the infectious factor, not as the only causally significant factor, but as a trigger and/or comorbid one. The review summarizes current data on the involvement of the most important microorganisms (pathogens, opportunistic microorganisms, and pathobionts) in the pathogenesis of UC and CD and considers their possible role in the induction, progression, and course of IBD. A possible relationship between IBD and bacteria belonging to the phyla Pseudomonadota ( Proteobacteria), Bacillota ( Firmicutes), Actinomycetota ( Actinobacteria), and Spirochaetota, archaea, fungi, and eukaryotic viruses is discussed. Bacteria such as adhesive-invasive strains of Escherichia coli (AIEC), Salmonella enterica Typhimurium, Campylobacter jejuni, Campylobacter concisus, enterohepatic species of Helicobacter (including Helicobacter bilis), Proteus spp., Aeromonas spp., Klebsiella pneumoniae, Yersinia enterocolitica, Clostridioides difficile, Enterococcus spp., Staphylococcus aureus, Mycobacterium avium subsp. paratuberculosis and Brachyspira spp. The involvement of methanogenic archaea, such as Methanobrevibacter smithii and Methanosphaera stadtmanae, in immunoinflammatory processes in IBD has been shown. The pro-inflammatory role of intestinal fungi Candida albicans, which produces the cytolytic toxin candidalysin, Candida tropicalis, which forms polymicrobial biofilms, and Debaryomyces hansenii, has been revealed. The role of eukaryotic viruses such as herpesviruses (cytomegalovirus, Epstein–Barr virus, human herpesvirus 6), enteropathogenic viruses (norovirus), enterovirus B, hepatitis B virus (Orthohepadnavirus) in the development of IBD is discussed. Particular attention is paid to the possible role of the SARS-CoV-2 (COVID-19) virus as a trigger of IBD. Key words: inflammatory bowel disease, infections, archaea, bacteria, viruses, fungi, dysbiosis, gut microbiota
期刊介绍:
The journal publishes original research works, reviews of literature, lectures, methodological recommendations, clinical observations. Main topics: problems of etiology, pathogenesis, clinical manifestations of infectious diseases, new techniques and methods of their diagnosis, prevention and treatment; special attention is paid to the problems of antibacterial and antiviral therapy, the use of immunoglobulins and interferons, and also to intensive therapy of critical states. The journal is in the List of leading scientific journals and periodicals of the Supreme Attestation Committee, where the principal results of doctoral dissertations should be published.